1. Johson & Johnson is embarking on a two-year restructuring process of its orthopedic business after its third quarter earnings report reflected a shortfall in medical device sales.
2. Johnson & Johnson posted increases in third quarter revenue and orthopedic sales.
3. DePuy Synthes, Johnson and Johnson’s orthopedic company, earned FDA 510(k) clearance for the TriALTIS spine system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
